Changes in drawing traits have been reported in people with early-stage cognitive impairments, but most studies have used a single drawing task only.
Scientists from the University of Tsukuba and IBM found that they could classify people with normal cognition, mild cognitive impairment (MCI), and Alzheimer’s disease (AD) with much greater accuracy by combining traits extracted from five drawing tasks compared to using just one or two tasks.
The research is published in the Journal of Alzheimer’s Disease and was conducted by Professor Tetsuaki Arai et al.
Around 75% of people with dementia have not been diagnosed, and this is partly because there is a lack of accurate screening tests that can be done outside of a doctor’s office or hospital.
In the study, the team wanted to address this lack of accurate screening tests using the automatic analysis of drawing.
They used five different drawing tests that capture different aspects of cognition and are commonly used when diagnosing AD and MCI.
While these tests were being performed, 22 different drawing features—relating to pen pressure, pen posture, speed, and pauses—were automatically analyzed per test.
The researchers then compared these features with scores from seven different tests of cognitive function and used a computer-based program to see how well the drawing traits could be used to identify people with normal cognition, MCI, or AD.
They were surprised by how well the combination of drawing traits extracted from multiple tasks worked by capturing different, complementary aspects of cognitive impairments.
The three-group classification accuracy of all five tests was 75.2%, which was almost 10% better than that of any of the tests by themselves.
In addition, the majority of the drawing features that were different between the three groups had greater changes between the normal and AD subjects compared with the normal and MCI subjects—this is important because MCI is often considered an early (and less severe) form of AD.
The team says with the ever-increasing numbers of therapies targeting the early stages of cognitive impairment, screening tests are becoming more important.
Better screening will lead to earlier diagnoses, which will, in turn, improve patients’ quality of life.
If you care about brain health, please read studies that including more wine and cheese in the diet may help reduce cognitive decline, and this exercise can benefit cognitive function in older people.
For more information about health, please see recent studies about how COVID-19 damages the brain, and results showing that brain parasites spread by cats affect 30 million Americans.
Copyright © 2022 Knowridge Science Report. All rights reserved.
